Axonics Financial Statements From 2010 to 2024
| 0I3 Stock | EUR 63.50 0.00 0.00% |
Check Axonics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Axonics' main balance sheet or income statement drivers, such as , as well as many indicators such as . Axonics financial statements analysis is a perfect complement when working with Axonics Valuation or Volatility modules.
Axonics |
Axonics Company Current Valuation Analysis
Axonics' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Axonics Current Valuation | 2.7 B |
Most of Axonics' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Axonics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Axonics has a Current Valuation of 2.7 B. This is 81.18% lower than that of the Healthcare sector and 78.24% lower than that of the Medical Devices industry. The current valuation for all Germany stocks is 83.74% higher than that of the company.
Axonics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Axonics's current stock value. Our valuation model uses many indicators to compare Axonics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Axonics competition to find correlations between indicators driving Axonics's intrinsic value. More Info.Axonics is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Axonics' earnings, one of the primary drivers of an investment's value.About Axonics Financial Statements
Axonics stakeholders use historical fundamental indicators, such as Axonics' revenue or net income, to determine how well the company is positioned to perform in the future. Although Axonics investors may analyze each financial statement separately, they are all interrelated. For example, changes in Axonics' assets and liabilities are reflected in the revenues and expenses on Axonics' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Axonics. Please read more on our technical analysis and fundamental analysis pages.
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation systems. Axonics, Inc. was incorporated in 2012 and is headquartered in Irvine, California. AXONICS INC operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 416 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Axonics Stock
Axonics financial ratios help investors to determine whether Axonics Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Axonics with respect to the benefits of owning Axonics security.